Kevin Fricka, MD
Adult Reconstructive Orthopaedic Surgery · Alexandria, VANPI 1689653784
Payments from drug & device makers
Across 417 payments — averaging $2061.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$825K
- Heron Therapeutics, Inc.$24K
- Zimmer Biomet$7K
- Orthalign Inc$3K
- Linkbio Corp$179
- Medical Device Business Services, Inc.$163
- plus $419 from 8 others
Across 2 payments — averaging $13,080 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Zimmer Biomet$26K
What the payments were for
- Royalty or licence$434,95456%
- Consulting fees$142,97119%
- Speaking & faculty fees$145,03119%
- Travel & lodging$37,1595%
- Food & beverage$12,5692%
- Gifts$1140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 336 | $824,761 |
| Heron Therapeutics, Inc. | 26 | $24,351 |
| Zimmer Biomet | 24 | $7,149 |
| Orthalign Inc | 18 | $2,716 |
| Linkbio Corp | 1 | $179 |
| Medical Device Business Services, Inc. | 2 | $163 |
| Engage Uni, LLC | 1 | $114 |
| Restor3d, Inc. | 1 | $102 |
| Johnson & Johnson(2 entities) | 2 | $66 |
| Innovation Technologies Inc | 2 | $56 |
| Cook Medical LLC | 1 | $27 |
| Avanos Medical | 1 | $21 |
| Baudax Bio Inc. | 1 | $20 |
| Vertex | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$1,179,907
- REAL INTELLIGENCE$138,101
- Engage Partial Knee System$45,825
- PICO$38,277
- Journey II BCS$27,397
- Journey II XR$25,782
- Journey II CR$25,397
- Zynrelef$23,985
- Journey Uni$18,722
- POLARSTEM$17,620
- JOURNEY II UK$17,538
- LEGION TKS$15,857
- K-15 PORK$14,381
- CORI$13,781
- NAVIO$12,581
- OXINIUM Knee$12,000
- VERILAST Knee$12,000
- JII Unicondylar Knee System$11,745
- BIRMINGHAM HIP$10,563
- Legion Revision$9,529
How this compares
$859,739 in reported general payments places this provider in the 90th percentile of 58 adult reconstructive orthopaedic surgery providers in Virginia.
See all adult reconstructive orthopaedic surgery providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 211 | $6,621 |
| Diclofenac Sodium ErDiclofenac Sodium | 29 | $656 |
| Meloxicam | 99 | $307 |
| Tramadol Hcl | 109 | $280 |
| Diclofenac Sodium | 22 | $222 |
| Oxycodone Hcl | 58 | $174 |
| Cefadroxil | 12 | $46 |
| Amoxicillin | 18 | $36 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Alexandria
- William HamiltonAlexandria$9.3M
- Craig McAseyAlexandria$32K
- Jason PedowitzAlexandria$8K
- Craig ShulAlexandria$5K
- Nitin GoyalArlington$81.5M
- Charles EnghArlington$5.5M
- James BrowneCharlottesville$4.8M
- Anthony CarterNewport News$586K
- John VelyvisMartinsville$484K
- Robert SershonArlington$289K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.